MMP15 and cervical carcinoma: In addition, we also revealed that cervical cancer patients with high expression of MMP15 had a shorter overall survival (OS) (HR = 1.8, 95% CI 1.06–3.05, p = 0.027) than those with low MMP15 expression (Figure 3E).